Synthesis and Structure-Activity Relationships of Indazole Arylsulfonamides as Allosteric CC-Chemokine Receptor 4 (CCR4) Antagonists

被引:40
作者
Procopiou, Panayiotis A. [1 ]
Barrett, John W. [3 ]
Barton, Nicholas P. [4 ]
Begg, Malcolm [2 ]
Clapham, David [5 ]
Copley, Royston C. B. [4 ]
Ford, Alison J. [2 ]
Graves, Rebecca H. [3 ]
Hall, David A. [2 ]
Hancock, Ashley P.
Hill, Alan P. [4 ]
Hobbs, Heather [1 ]
Hodgson, Simon T. [1 ]
Jumeaux, Coline [1 ]
Lacroix, Yannick M. L. [1 ]
Miah, Afjal H. [1 ]
Morriss, Karen M. L. [1 ]
Needham, Deborah [1 ]
Sheriff, Emma B. [3 ]
Slack, Robert J. [2 ]
Smith, Claire E. [3 ]
Sollis, Steven L. [1 ]
Staton, Hugo [1 ]
机构
[1] GlaxoSmithKline Med Res Ctr, Dept Med Chem, Stevenage SG1 2NY, Herts, England
[2] GlaxoSmithKline Med Res Ctr, Dept Resp Biol, Stevenage SG1 2NY, Herts, England
[3] GlaxoSmithKline Med Res Ctr, Dept Drug Metab & Pharmacokinet, Resp CEDD, Stevenage SG1 2NY, Herts, England
[4] GlaxoSmithKline Med Res Ctr, Computat & Struct Chem Dept, Stevenage SG1 2NY, Herts, England
[5] GlaxoSmithlthne, Res & Dev, Exploratory Dev Sci, Ware SG12 ODP, Herts, England
关键词
OPTIMIZATION; POTENT; IDENTIFICATION; MODELS; CELLS; SITE;
D O I
10.1021/jm301572h
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of indazole arylsulfonamides were synthesized and examined as human CCR4 antagonists. Methoxy- or hydroxyl- containing groups were the more potent indazole C4 substituents. Only small groups were tolerated at C5, C6, or C7, with the C6 analogues being preferred. The most potent N3-substituent was 5-chlorothiophene-2-sulfonamide. N1 meta-substituted benzyl groups possessing an alpha-amino-3-[(methylamino)acyl]- group were the most potent N1-substituents. Strongly basic amino groups had low oral absorption in vivo. Less basic analogues, such as morpholines, had good oral absorption; however, they also had high clearance. The most potent compound with high absorption in two species was analogue 6 (GSK2239633A), which was selected for further development. Aryl sulfonamide antagonists bind to CCR4 at an intracellular allosteric site denoted site II. X-ray diffraction studies on two indazole sulfonamide fragments suggested the presence of an important intramolecular interaction in the active conformation.
引用
收藏
页码:1946 / 1960
页数:15
相关论文
共 38 条
  • [1] An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5
    Andrews, Glen
    Jones, Carolyn
    Wreggett, Keith A.
    [J]. MOLECULAR PHARMACOLOGY, 2008, 73 (03) : 855 - 867
  • [2] ASHIMORI A, 1990, CHEM PHARM BULL, V38, P2446
  • [3] CC Chemokine Receptor 4 (CCR4) in human allergen-induced late nasal responses
    Banfield, G.
    Watanabe, H.
    Scadding, G.
    Jacobson, M. R.
    Till, S. J.
    Hall, D. A.
    Robinson, D. S.
    Lloyd, C. M.
    Nouri-Aria, K. T.
    Durham, S. R.
    [J]. ALLERGY, 2010, 65 (09) : 1126 - 1133
  • [4] Baxter A., 2003, [No title captured], Patent No. [2003059893, WO2003059893A1]
  • [5] Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s
    Bonecchi, R
    Bianchi, G
    Bordignon, PP
    D'Ambrosio, D
    Lang, R
    Borsatti, A
    Sozzani, S
    Allavena, P
    Gray, PA
    Mantovani, A
    Sinigaglia, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (01) : 129 - 134
  • [6] Small molecule antagonists of the CC chemokine receptor 4 (CCR4)
    Burdi, Douglas F.
    Chi, Shannon
    Mattia, Karen
    Harrington, Celeste
    Shi, Zhan
    Chen, Shaowu
    Jacutin-Porte, Swanee
    Bennett, Robert
    Carson, Kenneth
    Yin, Wei
    Kansra, Vikram
    Gonzalo, Jose-Angel
    Coyle, Anthony
    Jaffee, Bruce
    Ocain, Timothy
    Hodge, Marty
    LaRosa, Gregory
    Harriman, Geraldine
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (11) : 3141 - 3145
  • [7] Cahn A, SAFETY TOLERAB UNPUB
  • [8] Role of the Chemokine Receptors CCR1, CCR2 and CCR4 in the Pathogenesis of Experimental Dengue Infection in Mice
    Guabiraba, Rodrigo
    Marques, Rafael Elias
    Besnard, Anne-Gaelle
    Fagundes, Caio T.
    Souza, Danielle G.
    Ryffel, Bernhard
    Teixeira, Mauro M.
    [J]. PLOS ONE, 2010, 5 (12):
  • [9] Habashita H., 2004, [No title captured], Patent No. [WO 2004007472A1, 2004007472]
  • [10] Hartl Dominik, 2006, Inflammation & Allergy Drug Targets, V5, P219, DOI 10.2174/187152806779010972